ALEC - Alector Inc. Bozor kapitallashuvining daromadga nisbati
Joriy P/S koeffitsiyenti aksiyalar narxining antitelolarni test qilish natijalariga bog'liqligini ko'rsatmoqda, bunda qiymat 1.60 darajasida saqlanmoqda. Alector, Inc. (ALEC) mikrogliyalarni faollashtirish orqali Parkinson va Altsgeymer kasalliklarini davolash usullarini ishlab chiqadi. Ishlab chiqish jarayoni zamonaviy laboratoriyalarga kirish imkoniyatiga ega bo'lgan yetakchi tadqiqotchilar xodimlariga tayanadi. Kapital barqarorligi klinik ma'lumotlarni uzoq kutish davrida xavfsizlikni ta'minlaydi.
Alector, Inc. (ALEC) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi statistikasi:
- balans kapitallashuvi ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning xususiy kapitalga nisbati Alector, Inc.|ALEC - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti alector.com|ALEC - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Alector Therapeutics|ALEC - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzi Alector|Shoshilinch likvidlik alector.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
ALEC - Sof foyda|Kelajakdagi foyda Alector, Inc.|ALEC - Narxning foydaga nisbati|Narxning kelajakdagi foydaga nisbati alector.com|ALEC - PEG multiplikatori|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Alector Therapeutics|ALEC - Eskirish chegirilmasdan oldingi operatsion foyda|Bir aksiya uchun sof foyda (EPS TTM) Alector|ALEC - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi alector.com|ALEC - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Alector, Inc.
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning umumiy tahlili:ALEC Alector Inc.
P/S koeffitsiyenti bozor kapitalizatsiyasini yillik daromad bilan solishtiradi, bu esa biznes qiymatini uning daromad keltirish qobiliyatiga nisbatan baholash imkonini beradi. Tarixiy P/S tendentsiyalarini tahlil qilish orqali investor aktivning haddan tashqari sotib olinganligini aniqlashi mumkin, bu esa Alector, Inc. (ALEC) uchun juda muhimdir, chunki uning baholanishi Altsgeymer kasalligiga qarshi innovatsion immunoterapiya usullariga bo'lgan kuchli jamoaviy ishonchga asoslangan.
Alector, Inc. raqobatchilari
BIIB (biogen.com) - Bozor kapitallashuvining daromadga nisbati|Neurocrine Biosciences, Inc. - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati RGC|Axsome Therapeutics Inc - P/S multiplikatori|Narx/daromad koeffitsiyenti ACADIA Corp ACAD|Xenon Pharmaceuticals (XENE) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati VKTX|SUPN (Supernus) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Catalyst Pharma (CPRX)|Kapitalizatsiyaning daromadga nisbati DNLI (Denali Therapeutics Inc)|Narx/daromad koeffitsiyenti Harmony Corp|P/S multiplikatori BHVN (Biohaven Ltd.)|P/S multiplikatori amylyx.com AMLX|TRVI - Narxning daromadga nisbati|PRAX: Narxning daromadga nisbati|AVXL: P/S multiplikatori|Sotuvga nisbatan narx CeriBell EEG (CBLL)|PRTA (Prothena Biosciences) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati annexonbio.com (ANNX)|Narxning daromadga nisbati Omeros Corporation (OMER)|Neurogene Inc - Kapitalizatsiya va daromad nisbati|P/S multiplikatori ACIU (AC Immune Corp)|Voyager Corp (VYGR) - Sotuvga nisbatan narx|NMRA: Kapitalizatsiyaning daromadga nisbati|SCLX - P/S multiplikatori|Tevogen Bio (TVGN) - Narxning daromadga nisbati|Alpha Cognition Inc. - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Cognition Therapeutics, Inc.|Sotuvga nisbatan narx Inhibikase Pharma IKT|P/S multiplikatori SAVA|P/S multiplikatori assertiotx.com (ASRT)|Narxning daromadga nisbati Coya Therapeutics COYA|VistaGen Therapeutics, Inc. - Narxning daromadga nisbati|Ovid Rx - P/S multiplikatori|Sotuvga nisbatan narx Acumen Pharmaceuticals, Inc|CRVO: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Alterity Therapeutics Limited|Kapitalizatsiyaning daromadga nisbati CLNN|PEPG (PepGen Corp) - Kapitalizatsiyaning sotish hajmiga nisbati|Narxning daromadga nisbati Jupiter Neurosciences (JUNS)|RLMD - Sotuvga nisbatan narx|Narxning daromadga nisbati Annovis Bio, Inc. ANVS|Bozor kapitallashuvining daromadga nisbati GRCE|AIFF: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati KLTO (Klotho Neurosciences Inc)|NRSN: P/S multiplikatori|RVPH - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati MetaVia Inc.|Kapitalizatsiya va daromad nisbati NRXS (neuraxis.com)|P/S multiplikatori HSDT|Kapitalizatsiyaning daromadga nisbati passagebio.com PASG|Neuphoria Therapeutics - Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti Minerva (NERV)|Athira Pharma, Inc. - P/S multiplikatori|ADXN - P/S multiplikatori|alzamend.com (ALZN) - Narxning daromadga nisbati|CYCN (Cyclerion Therapeutics, Inc.) - Narxning daromadga nisbati|PTIX (Protagenic Therapeutics Inc.) - P/S multiplikatori|Sotuvga nisbatan narx Pasithea KTTA|P/S multiplikatori CRGT|Kapitalizatsiyaning daromadga nisbati avenuetx.com ATXI|Narxning daromadga nisbati BrainStorm Cell Therapeutics BCLI|CARA: Kapitalizatsiya va daromad nisbati|Chromocell Therapeutics Corporation - P/S multiplikatori|Sotuvga nisbatan narx Eliem Therapeutics|ITCI (intracellulartherapies.com) - Kapitalizatsiyaning daromadga nisbati|longboardpharma.com (LBPH) - P/S multiplikatori|Narxning daromadga nisbati Marinus Pharmaceuticals, Inc.|NKGN: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati NeuroBo (NRBO)|SAGE - Sotuvga nisbatan narx|P/S multiplikatori SNPX (Synaptogenix, Inc.)|P/S multiplikatori trevena.com TRVN|VIGL - Narxning daromadga nisbati|WENA: Narxning daromadga nisbati|CERE: P/S multiplikatori
